Detection of M. tuberculosis in the environment as a tool for identifying high-risk locations for tuberculosis transmission.


Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
15 Oct 2022
Historique:
received: 26 04 2022
revised: 21 06 2022
accepted: 21 06 2022
pubmed: 28 6 2022
medline: 24 8 2022
entrez: 27 6 2022
Statut: ppublish

Résumé

Tuberculosis (TB) remains a leading cause of infectious mortality globally, yet most cases cannot be epidemiologically linked even with extensive contact investigations and whole genome sequencing. Consequently, there remain major gaps in our understanding of where and when M. tuberculosis (Mtb) exposures occur. We aimed to investigate whether Mtb can be detected in environments where TB patients were recently present, which could serve as a tool for characterizing exposure risk. We collected 389 environment surface (ES) swabs from two high TB burden prisons in Brazil, sampling 41 (n = 340) cells occupied by individuals with active TB and 7 (n = 49) cells from individuals without TB. In a subset of pooled swabs (n = 6) and a swab from a cigarette lighter from the cell with active TB patients, we enriched Mtb DNA using RNA-bait hybrid capture assays and performed whole genome sequencing. In prison cells, Mtb DNA was detected in 55/340 (16 %) of ES swabs from cells occupied by active TB patients and none (0/49) from cells in which no active TB patients were present. Mtb was detected in 13/16 (81 %) prison cells occupied by the individuals with high/medium sputum Xpert Mtb load and 8/25 (32 %) with low/very low sputum Mtb load (p = 0.003). Seven hybrid capture samples had a median genomic coverage of 140×. rpoB mutations conferring high-level rifampin resistance were detected in 3/7 ES swabs. Mtb was frequently detectable in environments recently occupied by individuals with active TB. This approach could be applied in congregate environments to identify and characterize high-risk settings for Mtb exposure.

Identifiants

pubmed: 35760168
pii: S0048-9697(22)04067-0
doi: 10.1016/j.scitotenv.2022.156970
pii:
doi:

Substances chimiques

Rifampin VJT6J7R4TR

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

156970

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Jason R. Andrews reports financial support was provided by National Institutes of Health.

Auteurs

Renu Verma (R)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: vrenu@stanford.edu.

Flora Martinez Figueira Moreira (FMF)

Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.

Agne Oliveira do Prado Morais (AO)

Postgraduate Program in Infectious and Parasitic Diseases, Federal University of Mato Grosso do Sul, Mato Grosso do Sul, Brazil.

Katharine S Walter (KS)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Paulo César Pereira Dos Santos (PCP)

Postgraduate Program in Infectious and Parasitic Diseases, Federal University of Mato Grosso do Sul, Mato Grosso do Sul, Brazil.

Eugene Kim (E)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Thiego Ramon Soares (TR)

Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil.

Rafaele Carla Pivetta de Araujo (RCP)

Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil.

Bruna Oliveira da Silva (BO)

Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil.

Andrea da Silva Santos (A)

Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, MS, Brazil.

Julio Croda (J)

Oswaldo Cruz Foundation Mato Grosso do Sul, Mato Grosso do Sul, Brazil; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, USA; Federal University of Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil.

Jason R Andrews (JR)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH